Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
18.43
-1.09 (-5.58%)
May 9, 2025, 3:50 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Novel Therapeutics
7.02M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
1.99%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
7.02M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
1.99%
Log In
Log In
Log In
Log In
Upgrade